Fig. 1
Comparative analysis of clinical and endoscopic remission rates with ADA or IFX in patients with UC at weeks 8, 26 and 52 of treatment
Fig. 1 | BMC Gastroenterology
Comparative analysis of clinical and endoscopic remission rates with ADA or IFX in patients with UC at weeks 8, 26 and 52 of treatment